Skip to content
2000
Volume 6, Issue 1
  • ISSN: 1574-8928
  • E-ISSN: 2212-3970

Abstract

Despite recent advances in treatment of head and neck cancer, survival has not improved as expected. Bcl-2 family proteins play important role in regulating apoptosis. Recently, newer molecules have been developed for inhibition of Bcl-2 related proteins. We, herein aim to discuss the importance of Bcl-2 family proteins to the development of head and neck cancer and how the targeted-therapy for inhibition of Bcl-2 and related proteins, based on new drugs and recent patents, could improve the efficacy of the systemic therapy.

Loading

Article metrics loading...

/content/journals/pra/10.2174/157489211793980042
2011-01-01
2025-09-05
Loading full text...

Full text loading...

/content/journals/pra/10.2174/157489211793980042
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test